| First Author | Wirths O | Year | 2006 |
| Journal | Exp Gerontol | Volume | 41 |
| Issue | 2 | Pages | 220-4 |
| PubMed ID | 16307858 | Mgi Jnum | J:128243 |
| Mgi Id | MGI:3766543 | Doi | 10.1016/j.exger.2005.10.007 |
| Citation | Wirths O, et al. (2006) Decreased plasma cholesterol levels during aging in transgenic mouse models of Alzheimer's disease. Exp Gerontol 41(2):220-4 |
| abstractText | A large number of studies deals with the association of cholesterol and Abeta levels, however, the results are so far controversial. Whereas some studies report on increased cholesterol levels, other authors refer to an association of decreased peripheral cholesterol and the incidence of Alzheimer's disease. It is also questionable whether plasma cholesterol levels could be used as a predictive biomarker for the incidence of Alzheimer's disease. In the present report, we studied the relationship between these two parameters during aging in different transgenic mouse models of Alzheimer's disease, expressing both mutant human amyloid precursor protein and mutant human presenilin-1. Measurements of plasma cholesterol levels revealed a significant reduction in aged APP/PS1 and APP/PS1ki mice, whereas plasma levels in young and aged control mice remained almost unchanged. Furthermore, statistical analysis revealed a significant negative correlation between plasma cholesterol and brain Abeta42 levels during aging in the mice expressing both APP and PS1. |
